Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2

29Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Amantadine is a drug that can help in the prevention of SARS-CoV-2 symptomatology, as has been demonstrated in observational clinical studies. Methods: We searched in the PubMed database Clinical Studies of coronavirus-infected patients who have been treated with amantadine in a preventive manner as well as patients with Parkinson’s disease. Results: Four clinical studies were found in which relatives of patients with COVID-19 had been prescribed the use of amantadine in a preventive manner to avoid the symptoms caused by the coronavirus. Conclusion: Amantadine is a drug that can be prescribed as a prophylactic that prevents symptomatology caused by SARS-CoV-2 coronavirus.

Author supplied keywords

Cite

CITATION STYLE

APA

Cortés-Borra, A., & Aranda-Abreu, G. E. (2021). Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2. Pharmacological Reports, 73(3), 962–965. https://doi.org/10.1007/s43440-021-00231-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free